I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 26% ± 11% | |
| GABAergic neuron | 5 studies | 20% ± 4% | |
| interneuron | 3 studies | 37% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 26% ± 11% | |
| GABAergic neuron | 5 studies | 20% ± 4% | |
| interneuron | 3 studies | 37% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 92% | 2956.59 | 1329 / 1445 | 80% | 15.10 | 147 / 183 |
| lung | 87% | 1256.32 | 504 / 578 | 75% | 8.44 | 869 / 1155 |
| ovary | 100% | 3448.04 | 180 / 180 | 60% | 4.58 | 258 / 430 |
| brain | 68% | 1734.43 | 1805 / 2642 | 91% | 16.46 | 642 / 705 |
| breast | 69% | 822.32 | 317 / 459 | 78% | 5.99 | 872 / 1118 |
| uterus | 71% | 1004.31 | 121 / 170 | 58% | 6.36 | 266 / 459 |
| prostate | 61% | 799.53 | 149 / 245 | 60% | 3.09 | 300 / 502 |
| intestine | 71% | 1437.57 | 690 / 966 | 46% | 3.45 | 244 / 527 |
| stomach | 50% | 1177.92 | 181 / 359 | 63% | 6.84 | 181 / 286 |
| thymus | 60% | 753.65 | 390 / 653 | 54% | 3.54 | 324 / 605 |
| bladder | 76% | 1195.76 | 16 / 21 | 37% | 2.59 | 186 / 504 |
| blood vessel | 100% | 6709.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 10094.46 | 801 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 1% | 9.32 | 4 / 328 | 85% | 8.75 | 152 / 178 |
| heart | 86% | 1381.50 | 738 / 861 | 0% | 0 | 0 / 0 |
| adipose | 80% | 1247.93 | 962 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 71% | 8.09 | 32 / 45 |
| skin | 47% | 480.42 | 856 / 1809 | 18% | 1.17 | 87 / 472 |
| kidney | 8% | 65.70 | 7 / 89 | 46% | 3.04 | 410 / 901 |
| adrenal gland | 9% | 74.78 | 22 / 258 | 22% | 1.15 | 51 / 230 |
| liver | 0% | 0 | 0 / 226 | 20% | 1.34 | 80 / 406 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.19 | 5 / 80 |
| spleen | 1% | 13.10 | 3 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.75 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0070564 | Biological process | positive regulation of vitamin D receptor signaling pathway |
| GO_0001957 | Biological process | intramembranous ossification |
| GO_1902806 | Biological process | regulation of cell cycle G1/S phase transition |
| GO_0033689 | Biological process | negative regulation of osteoblast proliferation |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | MN1 |
| Protein name | MN1 proto-oncogene, transcriptional regulator Transcriptional activator MN1 (Probable tumor suppressor protein MN1) Meningioma (Disrupted in balanced translocation) 1 |
| Synonyms | |
| Description | FUNCTION: Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull (By similarity). May play a role in tumor suppression (Probable). . |
| Accessions | Q10571 ENST00000424656.1 ENST00000302326.5 A5HML1 H7C105 |
